Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1

Neuropharmacology

Volumn 93, Issue , 2015, Pages 308-313

  Espinoza, Stefano ^a   Ghisi, Valentina ^b   Emanuele, Marco ^a   Leo, Damiana ^a   Sukhanov, Ilya ^a   Sotnikova, Tatiana D ^a,c   Chieregatti, Evelina ^a   Gainetdinov, Raul R ^a,c,d  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

Author keywords

D2 receptor; Dopamine; Striatum; TAAR1

Indexed keywords

BETA CATENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG; BENZAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; MESSENGER RNA; PROTEIN BINDING; QUINPIROLE; SK&F 82958; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUPERSENSITIVITY; UPREGULATION; ANIMAL; C57BL MOUSE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; BENZAZEPINES; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84924081435     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.02.010     Document Type: Article

References (29)

1. A. Anzalone, J.E. Lizardi-Ortiz, M. Ramos, C. De Mei, F.W. Hopf, C. Iaccarino, B. Halbout, J. Jacobsen, C. Kinoshita, M. Welter, M.G. Caron, A. Bonci, D. Sulzer, and E. Borrelli Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors J. Neurosci. 32 2012 9023 9034
2. J.M. Beaulieu, S. Espinoza, and R.R. Gainetdinov Dopamine receptors: IUPHAR review 13 Br. J. Pharmacol. 172 1 2015 Jan 1 23
3. J.M. Beaulieu, and R.R. Gainetdinov The physiology, signaling, and pharmacology of dopamine receptors Pharmacol. Rev. 63 2011 182 217
4. J.M. Beaulieu, R.R. Gainetdinov, and M.G. Caron Akt/GSK3 signaling in the action of psychotropic drugs Annu Rev. Pharmacol. Toxicol. 49 2009 327 347
5. J.M. Beaulieu, S. Marion, R.M. Rodriguiz, I.O. Medvedev, T.D. Sotnikova, V. Ghisi, W.C. Wetsel, R.J. Lefkowitz, R.R. Gainetdinov, and M.G. Caron A beta-arrestin 2 signaling complex mediates lithium action on behavior Cell 132 2008 125 136
6. J.M. Beaulieu, T.D. Sotnikova, S. Marion, R.J. Lefkowitz, R.R. Gainetdinov, and M.G. Caron An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior Cell 122 2005 261 273
7. J.M. Beaulieu, T.D. Sotnikova, W.D. Yao, L. Kockeritz, J.R. Woodgett, R.R. Gainetdinov, and M.G. Caron Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc. Natl. Acad. Sci. U. S. A. 101 2004 5099 5104
8. B. Borowsky, N. Adham, K.A. Jones, R. Raddatz, R. Artymyshyn, K.L. Ogozalek, M.M. Durkin, P.P. Lakhlani, J.A. Bonini, S. Pathirana, N. Boyle, X. Pu, E. Kouranova, H. Lichtblau, F.Y. Ochoa, T.A. Branchek, and C. Gerald Trace amines: identification of a family of mammalian G protein-coupled receptors Proc. Natl. Acad. Sci. U. S. A. 98 2001 8966 8971
9. J.R. Bunzow, M.S. Sonders, S. Arttamangkul, L.M. Harrison, G. Zhang, D.I. Quigley, T. Darland, K.L. Suchland, S. Pasumamula, J.L. Kennedy, S.B. Olson, R.E. Magenis, S.G. Amara, and D.K. Grandy Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor Mol. Pharmacol. 60 2001 1181 1188
10. B. Di Cara, R. Maggio, G. Aloisi, J.M. Rivet, E.G. Lundius, T. Yoshitake, P. Svenningsson, M. Brocco, A. Gobert, L. De Groote, L. Cistarelli, S. Veiga, C. De Montrion, M. Rodriguez, J.P. Galizzi, B.P. Lockhart, F. Coge, J.A. Boutin, P. Vayer, P.M. Verdouw, L. Groenink, and M.J. Millan Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA) J. Neurosci. 31 2011 16928 16940
11. S. Espinoza, and R.R. Gainetdinov Neuronal functions and emerging pharmacology of TAAR1 Top. Med. Chem. 2014 10.1007/7355-2014-78 (in press)
12. S. Espinoza, A. Salahpour, B. Masri, T.D. Sotnikova, M. Messa, L.S. Barak, M.G. Caron, and R.R. Gainetdinov Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor Mol. Pharmacol. 80 2011 416 425
13. R.R. Gainetdinov, L.M. Bohn, T.D. Sotnikova, M. Cyr, A. Laakso, A.D. Macrae, G.E. Torres, K.M. Kim, R.J. Lefkowitz, M.G. Caron, and R.T. Premont Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice Neuron 38 2003 291 303
14. V. Ghisi, A.J. Ramsey, B. Masri, R.R. Gainetdinov, M.G. Caron, and A. Salahpour Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter Cell. Signal 21 2009 87 94
15. D. Leo, L. Mus, S. Espinoza, M.C. Hoener, T.D. Sotnikova, and R.R. Gainetdinov Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors Neuropharmacology 81 2014 283 291
16. L. Lindemann, and M.C. Hoener A renaissance in trace amines inspired by a novel GPCR family Trends Pharmacol. Sci. 26 2005 274 281
17. L. Lindemann, C.A. Meyer, K. Jeanneau, A. Bradaia, L. Ozmen, H. Bluethmann, B. Bettler, J.G. Wettstein, E. Borroni, J.L. Moreau, and M.C. Hoener Trace amine-associated receptor 1 modulates dopaminergic activity J. Pharmacol. Exp. Ther. 324 2008 948 956
18. F. Manago, S. Espinoza, A. Salahpour, T.D. Sotnikova, M.G. Caron, R.T. Premont, and R.R. Gainetdinov The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment Sci. Rep. 2 2012 301
19. G.M. Miller Avenues for the development of therapeutics that target Trace Amine Associated Receptor 1 (TAAR1) J. Med. Chem. 55 2012 1809 1814
20. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Bradaia, T.D. Sotnikova, R. Mory, S. Durkin, K.G. Zbinden, R. Norcross, C.A. Meyer, V. Metzler, S. Chaboz, L. Ozmen, G. Trube, B. Pouzet, B. Bettler, M.G. Caron, J.G. Wettstein, and M.C. Hoener TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Proc. Natl. Acad. Sci. U. S. A. 108 2011 8485 8490
21. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Ferragud, C. Velazquez-Sanchez, T.D. Sotnikova, S.R. Morairty, A. Harmeier, K. Groebke Zbinden, R.D. Norcross, A. Bradaia, T.S. Kilduff, B. Biemans, B. Pouzet, M.G. Caron, J.J. Canales, T.L. Wallace, J.G. Wettstein, and M.C. Hoener Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics Biol. Psychiatry 72 2012 934 942
22. F.G. Revel, J.L. Moreau, B. Pouzet, R. Mory, A. Bradaia, D. Buchy, V. Metzler, S. Chaboz, K. Groebke Zbinden, G. Galley, R.D. Norcross, D. Tuerck, A. Bruns, S.R. Morairty, T.S. Kilduff, T.L. Wallace, C. Risterucci, J.G. Wettstein, and M.C. Hoener A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight Mol. Psychiatry 18 2013 543 556
23. P. Seeman, D. Weinshenker, R. Quirion, L.K. Srivastava, S.K. Bhardwaj, D.K. Grandy, R.T. Premont, T.D. Sotnikova, P. Boksa, M. El-Ghundi, B.F. O'Dowd, S.R. George, M.L. Perreault, P.T. Mannisto, S. Robinson, R.D. Palmiter, and T. Tallerico Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis Proc. Natl. Acad. Sci. U. S. A. 102 2005 3513 3518
24. T.D. Sotnikova, J.M. Beaulieu, S. Espinoza, B. Masri, X. Zhang, A. Salahpour, L.S. Barak, M.G. Caron, and R.R. Gainetdinov The dopamine metabolite 3-methoxytyramine is a neuromodulator PLoS One 5 2010 e13452
25. T.D. Sotnikova, M.G. Caron, and R.R. Gainetdinov Trace amine-associated receptors as emerging therapeutic targets Mol. Pharmacol. 76 2009 229 235
26. I. Sukhanov, S. Espinoza, D.S. Yakovlev, M.C. Hoener, T.D. Sotnikova, and R.R. Gainetdinov TAAR1-dependent effects of apomorphine in mice Int. J. Neuropsychopharmacol. 17 10 2014 Oct 1683 1693
27. A. Usiello, J.H. Baik, F. Rouge-Pont, R. Picetti, A. Dierich, M. LeMeur, P.V. Piazza, and E. Borrelli Distinct functions of the two isoforms of dopamine D2 receptors Nature 408 2000 199 203
28. T.D. Wolinsky, C.J. Swanson, K.E. Smith, H. Zhong, B. Borowsky, P. Seeman, T. Branchek, and C.P. Gerald The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia Genes. Brain Behav. 6 2007 628 639
29. F. Xu, R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, L.M. Bohn, G.W. Miller, Y.M. Wang, and M.G. Caron Mice lacking the norepinephrine transporter are supersensitive to psychostimulants Nat. Neurosci. 3 2000 465 471